Nkarta (NKTX) Gains from Investment Securities (2019 - 2026)

Nkarta's quarterly Gains from Investment Securities came in at $1.3 million in Q1 2026, up 66.78% year-on-year from $778078.0 in Q1 2025, and down 87.91% quarter-over-quarter from $10.7 million in Q4 2025.

Nkarta has reported Gains from Investment Securities for 8 years, with the latest figure at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Gains from Investment Securities rose 66.78% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 66.78% YoY), and the FY2025 full-year result was $10.7 million, up 18.39% from the prior year.
  • Gains from Investment Securities for Q1 2026 stood at $1.3 million, down from $10.7 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $10.7 million in Q4 2025, with the low at $281206.0 in Q1 2024.
  • Average Gains from Investment Securities over 5 years is $3.8 million, with a median of $1.6 million recorded in 2022.
  • Peak annual rise in Gains from Investment Securities reached 6301.54% in 2022, while the deepest fall reached 86.49% in 2022.
  • Tracing NKTX's Gains from Investment Securities over 5 years: stood at $5.5 million in 2022, then increased by 21.69% to $6.7 million in 2023, then surged by 35.03% to $9.1 million in 2024, then gained by 18.39% to $10.7 million in 2025, then sank by 87.91% to $1.3 million in 2026.
  • The last three Gains from Investment Securities figures came in at $1.3 million (Q1 2026), $10.7 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Nkarta 232.80 Mn 232.80 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.30 Mn
Mar 31, 2026 1.30 Mn
Dec 31, 2025 10.74 Mn
Dec 31, 2025 10.74 Mn
Sep 30, 2025 4.45 Mn
Sep 30, 2025 4.45 Mn
Jun 30, 2025 4.40 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 778,078.00
Mar 31, 2025 778,078.00
Dec 31, 2024 9.07 Mn
Dec 31, 2024 9.07 Mn
Sep 30, 2024 9.10 Mn
Sep 30, 2024 9.10 Mn
Jun 30, 2024 326,848.00
Jun 30, 2024 326,848.00
Mar 31, 2024 281,206.00
Mar 31, 2024 281,206.00
Dec 31, 2023 6.72 Mn
Dec 31, 2023 6.72 Mn
Sep 30, 2023 7.13 Mn
Sep 30, 2023 7.13 Mn
Jun 30, 2023 503,639.00
Jun 30, 2023 503,639.00
Mar 31, 2023 700,000.00
Mar 31, 2023 700,000.00
Dec 31, 2022 5.52 Mn
Dec 31, 2022 5.52 Mn
Sep 30, 2022 565,915.00
Sep 30, 2022 565,915.00
Jun 30, 2022 1.64 Mn
Jun 30, 2022 1.64 Mn
Mar 31, 2022 1.01 Mn
Mar 31, 2022 1.01 Mn
Dec 31, 2021 4.20 Mn
Dec 31, 2021 4.20 Mn
Sep 30, 2021 4.19 Mn
Sep 30, 2021 4.19 Mn
Jun 30, 2021 4.29 Mn
Jun 30, 2021 4.29 Mn
Mar 31, 2021 15,732.00
Mar 31, 2021 15,732.00
Dec 31, 2020 -1,000.00
Dec 31, 2020 -1,000.00
Sep 30, 2020 3.56 Mn
Sep 30, 2020 3.56 Mn
Dec 31, 2019 2.33 Mn
Dec 31, 2019 2.33 Mn